Curated News
By: NewsRamp Editorial Staff
September 05, 2024
Aclarion, Inc. Announces Statewide Network for Nociscan in New Jersey
Discuss on Reddit
Discuss on SubstackTLDR
- Nociscan provides objective data for personal injury and workers compensation claims, giving an advantage in settlement negotiations.
- Nociscan uses MRS data and proprietary algorithms to noninvasively distinguish between painful and nonpainful discs in the lumbar spine.
- Nociscan aims to provide the right treatments and financial compensation to patients suffering from chronic low back pain, improving their quality of life.
- Aclarion, Inc. is leveraging biomarkers and AI to help physicians identify chronic low back pain, revolutionizing the healthcare technology industry.
Impact - Why it Matters
This news matters as it introduces a program to improve the objective evaluation of chronic low back pain patients in the personal injury and workers compensation system. The use of Nociscan is expected to provide important objective data that will impact the financial implications for workers, employers, and insurance companies.
Summary
The launch of a program to develop a statewide network of providers in New Jersey to utilize Nociscan throughout the personal injury and workers compensation population has been announced by Aclarion, Inc., a healthcare technology company. The initiative will be led by Justin Kubeck, M.D., who aims to improve the objective evaluation of chronic low back pain patients in the personal injury and workers compensation system. The use of Nociscan is expected to provide important objective data that providers can use as they formulate and defend their recommended treatment plan, ultimately impacting the financial implications for workers, employers, and insurance companies.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Aclarion, Inc. Announces Statewide Network for Nociscan in New Jersey
